Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients

Clinical trial NCT01872039 · COMPLETED

Trial details

NCT number: NCT01872039
Sponsor: Astellas Pharma China, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Emergency End-organ Damage

Start date: 2013-03-01
Primary completion: 2014-01-01
Enrollment: 163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.